No Data
No Data
No Data
No Data
No Data
Sector Update: Health Care Stocks Advance Premarket Monday
Health care stocks were advancing premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was up 0.5% and the iShares Biotechnology ETF (IBB) was 0.8% higher recently. Vaxxinity (VAXX) was r
MT NewswiresApr 22 09:11 ET
Kura Oncology Says Potential Leukemia Drug Ziftomenib Gets FDA Breakthrough Therapy Designation
Kura Oncology (KURA) said Monday the US Food and Drug Administration has granted Breakthrough Therapy Designation for its potential leukemia drug ziftomenib.
MT NewswiresApr 22 08:17 ET
Kura Oncology Gets Breakthrough Designation For Leukemia Therapy
Kura Oncology said Monday it received a breakthrough therapy designation from regulators for ziftomenib, its potential treatment for a form of leukemia.
WSJApr 22 08:13 ET
Express News | Kura Oncology Shares Are Trading Higher After the Company Received FDA Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Moomoo 24/7Apr 22 07:39 ET
Kura Oncology's Ziftomenib, Has Been Granted FDA Breakthrough Therapy Designation For Relapsed/Refractory NPM1-mutant Acute Myeloid Leukemia
Kura Oncology's Ziftomenib, Has Been Granted FDA Breakthrough Therapy Designation For Relapsed/Refractory NPM1-mutant Acute Myeloid Leukemia
BenzingaApr 22 07:32 ET
Express News | Kura Oncology Inc - Registration-Directed Trial of Ziftomenib in Npm1-Mutant Aml on Track to Complete Enrollment by Mid-2024
Moomoo 24/7Apr 22 07:30 ET
No Data
No Data